The biotechnology and pharmaceutical industries are an integral, vital, and growing part of the search for a cure for type 1diabetes. JDRF is focused on establishing partnerships with both pharmaceutical and biotechnology companies to accelerate the discovery, development, and commercialization of disease-modifying therapeutics and devices to better treat and cure type 1 diabetes and its complications. Our current portfolio includes the following industry partnerships:
